343269-72-7 Usage
Uses
Used in Cardiovascular Applications:
(1-PROPYL-1H-IMIDAZOL-2-YL)-METHANOL HCL is used as an antihypertensive agent for managing high blood pressure. It helps in relaxing blood vessels, which in turn lowers the blood pressure and reduces the strain on the heart.
Used in Angina Treatment:
In the treatment of angina, (1-PROPYL-1H-IMIDAZOL-2-YL)-METHANOL HCL is used as a beta blocker to alleviate chest pain and discomfort caused by insufficient blood flow to the heart.
Used in Tremor Management:
(1-PROPYL-1H-IMIDAZOL-2-YL)-METHANOL HCL is used as a tremor-reducing medication, helping to control involuntary shaking or trembling in individuals with conditions such as Parkinson's disease or essential tremor.
Used in Migraine Prevention:
In the field of neurology, (1-PROPYL-1H-IMIDAZOL-2-YL)-METHANOL HCL is used as a prophylactic treatment for migraines, working to prevent the occurrence of migraine headaches and reduce their severity and frequency.
Administration and Side Effects:
This medication is available in various forms, including tablets, extended-release capsules, and oral solutions, and is typically taken orally. Some common side effects of (1-PROPYL-1H-IMIDAZOL-2-YL)-METHANOL HCL may include dizziness, fatigue, and nausea. It is crucial to adhere to the prescribed dosage and usage instructions to minimize the risk of adverse effects.
Check Digit Verification of cas no
The CAS Registry Mumber 343269-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,3,2,6 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 343269-72:
(8*3)+(7*4)+(6*3)+(5*2)+(4*6)+(3*9)+(2*7)+(1*2)=147
147 % 10 = 7
So 343269-72-7 is a valid CAS Registry Number.
343269-72-7Relevant academic research and scientific papers
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety
Seto, Masaki,Miyamoto, Naoki,Aikawa, Katsuji,Aramaki, Yoshio,Kanzaki, Naoyuki,Iizawa, Yuji,Baba, Masanori,Shiraishi, Mitsuru
, p. 363 - 386 (2007/10/03)
In order to develop orally active CCR5 antagonists, 1-propyl- or 1-isobutyl-1-benzazepine derivatives containing a sulfoxide moiety have been designed, synthesized, and evaluated for their biological activities. Sulfoxide compounds containing a 2-pyridyl
BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
-
Page 236, (2010/02/06)
The present invention provides a novel benzazepine derivative represented by formula : wherein, R1 is a 5- or 6-membered aromatic ring, R2 is lower alkyl group, etc., Y is an optionally substituted imino group, ring A and ring B are independently an optionally substituted aromatic ring, W is formula -W1-X2-W2- (W1 and W2 are independently S(O)m1 (m1 is 0, 1 or 2), etc., and X2 is an optionally substituted alkylene groupetc. ), a preparation method and use thereof.
